Literature DB >> 6422023

The effect of prostacyclin on the adhesion of leucocytes to injured vascular endothelium.

G Jones, J V Hurley.   

Abstract

The effect of local application of various solutions on leucocyte adherence to the wall of small blood vessels in the microcirculation of the rat mesentery was examined. Leucocyte adhesion was produced by local application of zymosan-activated complement. Solutions of EDTA, lignocaine and prostacyclin when applied locally cause the release of a high proportion of leucocytes previously firmly adherent to the endothelium of venules and small veins without producing any significant change in the rate of blood flow through the affected vessels. Acetylcholine injected intravenously increases the rate of blood flow through the mesenteric microcirculation several fold but has no apparent effect on pre-existing leucocyte sticking. The findings suggest that in normal small blood vessels production of prostacyclin by vascular endothelium may inhibit adhesion of leucocytes to the vascular wall. When endothelium is injured local production of prostacyclin may be inhibited sufficiently to permit adhesion of leucocytes to the injured endothelium and so induce the earliest stage in the emigration of leucocytes into the area of injury. Lignocaine may possibly inhibit leucocyte sticking by increasing local production of prostacyclin, but the mode of action of EDTA and many other aspects of the mechanism responsible for leucocyte sticking remain obscure.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6422023     DOI: 10.1002/path.1711420110

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  14 in total

1.  Is there a place for prostacyclin in the treatment of septic shock?

Authors:  D De Backer
Journal:  Intensive Care Med       Date:  2001-07       Impact factor: 17.440

Review 2.  Is granulocyte or endothelial cell activation responsible for the initiation of granulocyte recruitment during acute inflammation?

Authors:  C J Whelan
Journal:  Agents Actions       Date:  1992-11

3.  Interaction between enteroviruses and human endothelial cells in vitro. Alterations in the physical properties of endothelial cell plasma membrane and adhesion of human granulocytes.

Authors:  C J Kirkpatrick; B D Bültmann; H Gruler
Journal:  Am J Pathol       Date:  1985-01       Impact factor: 4.307

Review 4.  The therapeutic value of vasodilator prostaglandins in multiple organ failure associated with sepsis.

Authors:  D J Bihari; J Tinker
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

5.  Inhibition of red cell membrane lipid peroxidation by sulphasalazine and 5-aminosalicylic acid.

Authors:  S M Greenfield; N A Punchard; R P Thompson
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

6.  Leukocyte hydrogen peroxide production in a surgical wound in mice. The effects of an amide local anaesthetic.

Authors:  A S Eriksson; R Sinclair
Journal:  Inflammation       Date:  1996-10       Impact factor: 4.092

7.  Pulmonary and haemodynamic effects of extracorporeal circulation in the cat and the beneficial effects of prostacyclin.

Authors:  J Jahr; P O Grände
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

8.  Prostacyclin counteracts the increase in capillary permeability induced by tumour necrosis factor-alpha.

Authors:  J Jahr; P O Grände
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

9.  Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration.

Authors:  M Rampart; T J Williams
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

10.  Effects of ischemic preconditioning and iloprost on myocardial ischemia-reperfusion damage in rats.

Authors:  Yasin Ay; Ibrahim Kara; Cemalettin Aydin; Nuray Kahraman Ay; Melike Elif Teker; Serkan Senol; Bekir Inan; Halil Basel; Omer Uysal; Rahmi Zeybek
Journal:  Int J Clin Exp Med       Date:  2013-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.